Serum amyloid A and metabolic disease: evidence for a critical role in chronic inflammatory conditions.

Front Cardiovasc Med · 2023 · PMC10311072 · PMID 37396595

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

In one clinical trial, SAA was a highly significant predictor of CD severity, and treatment with filgotinib, a selective JAK1/STAT inhibitor, improved CD symptoms while simultaneously reducing circulating SAA levels ( 223 ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.